Check out these unexpected drops with low-key names that might very well make for big gain
Check out these unexpected drops with low-key names that might very well make for big gain
The "Tissue Engineering - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Top Players Covered in the US Genetic Testing Market Research Report Are Invitae Corporation (San Francisco, U.S.), Ambry Genetics (Aliso Viejo, U.S.), BioReference Laboratories, Inc. (Elmwood Park, U.S.), Progenity, Inc. (San Diego, U.S.), Quest Diagnostics Incorporated (Secaucus, U.S.), Myriad Genetics, Inc. (Salt Lake City, U.S.), Fulgent Genetics (Temple City, U.S.), Burning Rock Biotech Limited (Guangzhou, China) and other key market players.Pune, India, May 17, 2021 (GLOBE NEWSWIRE) -- US Genetic Testing Market Size| 2021 Covid-19 Impact On Automotive Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2026 is latest study published by Fortune Business Insights. The US Genetic Testing Market size is expected to gain momentum by reaching USD 10.29 billion by 2027 while exhibiting an impressive CAGR of 13.0% between 2020 and 2027. This information is published by Fortune Business Insights in its latest report, titled, “U.S. Genetic Testing Industry, 2020-2027.” The report further mentions that the market stood at USD 4.11 billion in 2019. Factors such as increasing prevalence of chronic disorders and the increasing awareness regarding the efficacy of genetic testing in the U.S. will contribute to the growth of the market during the forecast period. Global US Genetic Testing Market Highlights: The US Genetic Testing Market report offers an in-depth analysis of the U.S. Genetic Testing industry and the demand drivers by highlighting information on several aspects of the market. Prudent Markets addresses all these aspects and provides the latest scoop and detailed eye-opening study on all major & emerging business segments. In addition to this, the report sheds light on the industry developments by key players, which are contributing to the expansion of this industry. The development scope, feasibility study, US Genetic Testing Market concentration, and maturity analysis is elaborated in this report. Information given in the research report pertains to different technological advancements introduced in recent years, which allows for a meticulous analysis of the industry and offers a more comprehensive understanding to the readers. Market to Exhibit 6.7% Growth in 2020 amid COVID-19 The market for genetic testing in the U.S. is expected to register a lower growth by exhibiting a CAGR of 6.7% in 2020. Factors such as cancellation and postponement of non-essential diagnostics such as that of hereditary disease and cancer screening and more impetus on COVID-19 screening is expected to lead to sluggish growth of the market. However, favorable government policies and proactive steps to widen the reach of screening amongst patients by the companies is expected to contribute to the growth of the U.S. Genetic Testing Industry in the forthcoming years. Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/u-s-genetic-testing-market-105034 The outbreak of covid-19 in the global market has made companies uncertain about their future scenario as the prolonged lock-down finds a serious economic slump. The latest survey on COVID-19 Outbreak-Global US Genetic Testing Market is conducted to provide hidden gems performance analysis. Essential growth factors and study of Basis points [BPS] have been discussed in the following report. Research Report explains a detailed overview of market dynamics, segmentation, product portfolio, business plans, and the latest development in the industry. Increasing Prevalence of Chronic Disorders to Augment Growth According to the Centers for Disease Control and Prevention (CDC), chronic ailments such as cancer, heart disorders, and diabetes are the leading cause of disability and deaths of people across the U.S. Moreover, the U.S. healthcare system suffers an estimated USD 320 billion annually, in direct and indirect costs. Therefore, to reduce the healthcare costs, several healthcare companies contemplate offering advanced screening solutions to detect the disease at the preliminary stage and further prevent disease fatality. Moreover, increasing awareness regarding the efficacy of the genetic testing methods amongst the healthcare professionals is expected to favor the US Genetic Testing Market growth in the forthcoming years. This report focuses on U.S. Genetic Testing Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2026, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market. Partnership between Major Companies to Amplify Their Market Positions The market is fragmented by the presence of major companies such as Myriad Genetics and Quest Diagnostics trying to maintain a stronghold by partnering other companies to expand their product portfolio. Moreover, the other companies such as Ambry Genetics, Invitae Corporation, and BioReference Laboratories are adopting strategies such as merger and acquisition to maintain their presence and gain a competitive edge over their rivals in the forthcoming years. Click here to get the short-term and long-term impact of COVID-19 on this Market.Please visit: https://www.fortunebusinessinsights.com/u-s-genetic-testing-market-105034 What does the Report Provide? The market report provides a qualitative and quantitative analysis of the market and focuses on key aspects such as the regulatory overview, key industry developments such as mergers, acquisitions, and partnerships, and funding raised by start-up companies that will impact the market. Additionally, the report offers valuable insights into the latest market trends and highlights key industry dynamics by adopting several research methodologies during the forecast period. Quick Buy - US Genetic Testing Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/105034 List of the Companies Profiled in the Market: Invitae Corporation (San Francisco, U.S.)Ambry Genetics (Aliso Viejo, U.S.)BioReference Laboratories, Inc. (Elmwood Park, U.S.)Progenity, Inc. (San Diego, U.S.)Quest Diagnostics Incorporated (Secaucus, U.S.)Myriad Genetics, Inc. (Salt Lake City, U.S.)Fulgent Genetics (Temple City, U.S.)Burning Rock Biotech Limited (Guangzhou, China) Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-genetic-testing-market-105034 Some major points from Table of Content: Introduction Research ScopeMarket SegmentationResearch MethodologyDefinitions and Assumptions Executive SummaryMarket Dynamics Market DriversMarket RestraintsMarket Opportunities Key Insights Regulatory OverviewOverview: Funding Raised by Genetic Testing focused Start-up CompaniesKey Industry Developments - Mergers, Acquisitions, and PartnershipPorter’s Five Forces AnalysisSWOT AnalysisImpact of COVID-19 Pandemic on the US Genetic Testing MarketAnalysis of Transactions in the Molecular Diagnostic Clinical Laboratory MarketOverview: Personalized Medicine Market Size (USD billion), U.S., 2019Reimbursement Scenario U.S. Genetic Testing Industry Analysis, Insights and Forecast, 2016-2027 Key Findings / SummaryMarket Analysis, Insights and Forecast – By Technique PCRDNA SequencingMicroarraysOthers Market Analysis, Insights and Forecast – By Application CardiologyOncologyPharmacogenomicsCognitive DysfunctionPathogenomicsOthers Market Analysis, Insights and Forecast – By Payer Public Health InsurancePrivate Health InsuranceOut-of-Pocket Market Analysis, Insights and Forecast – By End User HospitalsIndependent Laboratories Competitive Analysis U.S. Market Share Analysis (2019)Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based On Availability)) Invitae CorporationAmbry GeneticsBioReference Laboratories, Inc.Progenity, Inc.PathemaGXQuest Diagnostics IncorporatedMyriad Genetics, Inc.Fulgent GeneticsBurning Rock Biotech Limited Continued... Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/u-s-genetic-testing-market-105034 Have a Look at Related Reports: Ophthalmic Lasers Market Size, Share and Industry Analysis By Type (Excimer Lasers, Femtosecond Lasers, Nd Yag Lasers, Diode Lasers), Technology (Photodisruption, Selective Laser Trabeculoplasty, Photocoagulation), Application (Cataract Treatment, Glaucoma Treatment, Refractive Errors Treatment), End-User (Ophthalmic Laser Centers,Hospitals ) & Regional Forecast, 2019 – 2026 Hiv/Aids Drugs Market Size, Share and Industry Analysis By Drug Class (Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Integrase Inhibitors, Combination HIV Medicines, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026 Cancer Cachexia Market Size, Share & Covid-19 Impact Analysis, By Product (Progestogens, Corticosteroids, Combination Therapies, and Others), By Distributional Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027 Gene Therapy Market Size, Share & COVID-19 Impact Analysis, By Application (Oncology, Neurology, and Others), By Vector Type (Viral and Non-viral), By Distribution Channel (Hospitals, Clinics, and Others), and Regional Forecast, 2020-2027 Vitamin D Testing Market Size, Share and Industry Analysis By Product (25 -Hydroxy Vitamin D Testing, 1,25-Dihydroxy Vitamin D Testing, 24,25-Dihydroxy Vitamin D Testing), By Application (Clinical Testing, Research Testing), By End User (Diagnostic Laboratories, Hospitals & Clinics, Others), and Regional Forecast 2019-2026 About Us: Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges. Contact Us: Fortune Business Insights™ Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India. Phone:US :+1 424 253 0390UK : +44 2071 939123APAC : +91 744 740 1245Email: email@example.comFortune Business Insights™LinkedIn | Twitter | Blogs
The online used car seller with the giant "vending machines" has a business model well-suited to the pandemic era. What it doesn't have are profits.
May 17—Mike Tripp enjoyed bartending and chatting with customers at the High Tide Restaurant and Bar in Brewer, but the extra COVID-19 safety precautions plus the already fast pace of the job wore on him and he left a couple of months ago. "I had a great boss and co-workers, a great stack of regulars, but when you wear a mask all day on your shift you can really get gassed a lot quicker, and ...
The "UK Female Hair Piece, Wig, and Extension Market by Product Type, By Material: Opportunity Analysis and Industry Forecast, 2021-2027" report has been added to ResearchAndMarkets.com's offering.
Spectroscopy Market Research Report by Technology (Atomic, Mass, and Molecular), by Application (Environmental, Industrial, and Life Sciences) - Global Forecast to 2025 - Cumulative Impact of COVID-19New York, May 17, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Spectroscopy Market Research Report by Technology, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05911599/?utm_source=GNW Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.1. The Global Spectroscopy Market is expected to grow from USD 10,860.23 Million in 2020 to USD 14,358.03 Million by the end of 2025.2. The Global Spectroscopy Market is expected to grow from EUR 9,522.45 Million in 2020 to EUR 12,589.40 Million by the end of 2025.3. The Global Spectroscopy Market is expected to grow from GBP 8,465.48 Million in 2020 to GBP 11,192.00 Million by the end of 2025.4. The Global Spectroscopy Market is expected to grow from JPY 1,159,061.99 Million in 2020 to JPY 1,532,366.52 Million by the end of 2025.5. The Global Spectroscopy Market is expected to grow from AUD 15,770.50 Million in 2020 to AUD 20,849.78 Million by the end of 2025.Market Segmentation & Coverage:This research report categorizes the Spectroscopy to forecast the revenues and analyze the trends in each of the following sub-markets:Based on Technology, the Spectroscopy Market studied across Atomic, Mass, and Molecular. Based on Application, the Spectroscopy Market studied across Environmental, Industrial, and Life Sciences. Based on Geography, the Spectroscopy Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Spectroscopy Market including Agilent Technologies, Inc., BaySpec, Inc., Bristol Instruments, Inc., Bruker Corporation, Carl Zeiss AG, Danaher Corporation, Foss A/S, GBC Scientific Equipment Pty Ltd, Hitachi High-technologies Corporation, Horiba, Ltd., JASCO International Co., Ltd., Lumex Instruments, Metal Power Analytical Pvt. Ltd., Microptik BV, PerkinElmer, Inc., Rigaku Corporation, Sartorius AG, SCIEX, Shimadzu Corporation, Teledyne Technologies Incorporated, Thermo Fisher Scientific, Inc, Wasatch Photonics, and Waters Corporation. Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Spectroscopy Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Spectroscopy Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Spectroscopy Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Spectroscopy Market?4. What is the competitive strategic window for opportunities in the Global Spectroscopy Market?5. What are the technology trends and regulatory frameworks in the Global Spectroscopy Market?6. What are the modes and strategic moves considered suitable for entering the Global Spectroscopy Market?Read the full report: https://www.reportlinker.com/p05911599/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
May 17—PLATTSBURGH — Clinton County will again forgo holding a foreclosure auction this year. The decision was made after the state extended a moratorium put in place by the COVID-19 Emergency Eviction and Foreclosure Prevention Act of 2020 through Aug. 31. SHIFT TO NEXT YEAR Clinton County Treasurer Kimberly Davis explained that, in a normal year, the county would have foreclosed on ...
The Basketball Africa League (BAL) and Genius Sports today announced a data partnership that makes Genius Sports the Official Provider of Real-Time BAL Statistics. The announcement comes following the BAL’s debut, which tipped off this Sunday, May 16 at the Kigali Arena in Kigali, Rwanda, with 12 teams from across Africa competing in the new professional league. The first BAL Finals will be held Sunday, May 30.
VANCOUVER, British Columbia, May 17, 2021 (GLOBE NEWSWIRE) -- GT Gold Corp. (TSX-V:GTT; OTCQX:GTGDF) (the “Company” or “GT Gold”) is pleased to announce the successful completion of the previously-announced plan of arrangement with Newmont Corporation i under the Business Corporations Act (British Columbia) (the “Arrangement”). Pursuant to the Arrangement, Newmont has acquired the remaining 85.1% of the outstanding common shares of the Company not already owned by Newmont or its affiliates. Upon completion of the Arrangement, GT Gold became an indirect wholly-owned subsidiary of Newmont. “Newmont is excited to have the Tatogga project in the highly-sought after Golden Triangle district of British Columbia, Canada, become part of our world-class portfolio and part of our future,” said Newmont President and CEO Tom Palmer. “We look forward to continuing to build a respectful and meaningful relationship with the Tahltan Nation, including the community of Iskut. The relationships we have with Indigenous communities, First Nations and host communities are critical to the way we operate, and we look forward to partnering with the Tahltan Nation at all levels, and with the Government of British Columbia to ensure a shared path forward as we understand that Tahltan consent is necessary for advancing the project.” Ashwath Mehra, Executive Chair of GT Gold stated, “We are delighted to close this Transaction with Newmont today, representing the execution of our plan and the culmination of significant value creation for GT Gold shareholders since the formation of the Company just a few years ago. As we pass custody of this world-class property to Newmont, we are sure it is in the best hands. I would like to thank the whole team of employees, consultants, advisors and directors, who over the years have helped create GT Gold and made it what is today.” The Arrangement was approved by GT Gold’s shareholders at a special meeting held on May 6, 2021, and by the Supreme Court of British Columbia on May 10, 2021. Under the terms of the Arrangement, shareholders of GT Gold (other than Newmont and its affiliates), will receive C$3.25 per GT Gold common share in cash. The Company expects that its common shares will be delisted from the TSX Venture Exchange on or about May 21, 2021, and the Company intends to promptly apply to cease to be a reporting issuer in Alberta and British Columbia. Newmont trades on the New York Stock Exchange (NYSE: NEM) and on the Toronto Stock Exchange (TSX: NGT). Arrangement Questions Registered GT Gold shareholders who have questions or require assistance with submitting their shares to the Arrangement may direct their questions to Computershare Investor Services Inc., who is acting as depositary under the Arrangement. Non-registered GT Gold shareholders should contact their brokers or other intermediary with any questions or for instructions or assistance with submitting their shares for the Arrangement. Further information regarding the Arrangement is available in the Company’s management information circular dated April 6, 2021, which is available under GT Gold’s profile on SEDAR at www.sedar.com. About GT Gold Corp. GT Gold is engaged in advancing its wholly-owned, 47,500 hectare Tatogga property, located in the renowned "Golden Triangle" near Iskut, British Columbia. To date, GT Gold has made two significant discoveries on the Tatogga property, "Saddle South", a precious metal rich vein system and "Saddle North", a gold-rich copper porphyry system. About Newmont Corporation Newmont is the world’s leading gold company and a producer of copper, silver, zinc and lead. The Company’s world-class portfolio of assets, prospects and talent is anchored in favorable mining jurisdictions in North America, South America, Australia and Africa. Newmont is the only gold producer listed in the S&P 500 Index and is widely recognized for its principled environmental, social and governance practices. Newmont is an industry leader in value creation, supported by robust safety standards, superior execution and technical expertise. Newmont was founded in 1921 and has been publicly traded since 1925. For further information, please contact: GT Gold Corp.General Informationinfo@gtgoldcorp.caWebsite: www.gtgoldcorp.caNewmont CorporationEric ColbyVice President, Investor Relations and Corporate CommunicationsEric.Colby@newmont.comTel: (303) 837 2724 Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Today’s headlines: Amazon debuts another free video streaming service in India, Sharp is still making smartphones and its latest device has a huge one-inch camera sensor and Tesla's Model S Plaid may pack a retractable spoiler.
Palatin (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor system, today announced results for its third fiscal quarter ended March 31, 2021.
NextEra Energy Partners, LP (NYSE: NEP) today announced that it has entered into an amended agreement to upsize by $150 million its existing convertible equity portfolio financing with KKR (the Investor), through its core infrastructure strategy. NextEra Energy Partners originally entered into the 10-year convertible equity portfolio financing in November 2020.
Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced its financial and operational results for the three months ended March 31, 2021. For further details on the results, please refer to Miravo's Management, Discussion and Analysis (MD&A) and Condensed Consolidated Interim Financial Statements for the three months ended March 31, 2021, which are available on the Company's website (www.miravohealthcare.com). All figures are in Canadian dollars, unless otherwise noted.
According to a research report "Aircraft Heat Exchanger Market by Application (Environmental Control System and Engine System), Type (Plate-Fin, Flat Tube), Vendor (OEM, Aftermarket), Platform (Fixed-Wing Aircraft, Rotary-Wing Aircraft, and UAVS), and Region - Global Forecast to 2026", published by MarketsandMarkets™, the Aircraft Heat Exchanger Market is expected to grow from an estimated USD 1.3 billion in 2021 to USD 2.0 billion by 2026, at a CAGR of 9.2% during the forecast period of 2021-2026. Some of the factors fueling the market's growth include increasing demand for effective cooling and heating in commercial aircrafts and increase in military spending in many countries worldwide.
Siguler Guff, a leading multi-strategy private equity investment firm with $15 billion of assets under management, announced today that it has raised $240 million for its first direct investment emerging markets fund, GEMCo (or the "Fund").
Top Players Covered in the Vaccines Market Research Report are GlaxoSmithKline plc., Sanofi, Pfizer Inc., Merck & Co., Inc., Novartis AG, Emergent BioSolutions, Inc., CSL Limited, Inovio Pharmaceuticals, Inc., Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation and other key market players.Pune, India, May 17, 2021 (GLOBE NEWSWIRE) -- The global business vaccines market share is projected to reach USD 104.87 billion by 2027, exhibiting a CAGR of 10.7 % during the forecast period due to rise in infectious diseases observes, Fortune Business Insights™ in a published report, titled, “Vaccines Market, 2020-2027.” The increasing prevalence of infectious diseases such as HIV, Hepatitis, and Tuberculosis is making governments and pharmaceutical industries make enormous investments towards vaccine development. For instance, the COVID pandemic recorded more than 80 million cases worldwide, and many manufactures have pipelined their product to treat the disease, which will fuel the market in upcoming years COVID-19 Pandemic: Covid-19 has affected the market due to lower vaccination rates in low economic countries. However, the market is expected to see positive growth in upcoming years due to the rise in research and investments in healthcare. Moreover, the launch of various COVID-19 vaccines by key players such as Pfizer, Moderna is expected to fuel the market in upcoming years. Request a Sample Copy of the Global Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/vaccines-market-101769 Industry Development September 2019: African nations Kenya, Ghana, and Malawi in collaboration, launched the world’s first vaccine for treating malaria, as malaria is highly prevalent and is a major cause of death in Africa. Global Immunization Program to Drive the Vaccines Market Growth Demand for vaccines is growing globally to fulfill the immunization drive launched by the different governments to eradicate certain endemic diseases. For example, in India, the government surveillanced the immunization program to 21 lakh children for the pneumococcal conjugate vaccine. Moreover, due to COVID the ones in the pipeline will also promote the market in upcoming years. Several key players such as Novavax, Merck, GSK, and Pfizer will contribute to the market positively. On the other hand, the high cost of vaccines is the major restraint of the market. For example, in the US, the vaccine for Hepatitis A/B is $100; thus this high cost makes it unaffordable for people with low income and even major developing economies to buy vaccines for their citizens. To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/industry-reports/vaccines-market-101769 Segmentation Based on type, the market is divided into recombinant, conjugate, subunit, inactivated, live attenuated, and toxoid. By the route of administration, it is segmented into parenteral and oral. Based on disease indication, it is segmented into viral and bacterial diseases. By age group, the market is bifurcated into pediatric and adults. The market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa in terms of geography. Highlights of the Report The report gives a thorough analysis of the latest market trends, top market segments, and major driving factors. The different market segments and their regional analysis are also comprehensively discussed in the report. Additionally, the report talks about the dominant strategies adopted by key market players and the impact of COVID-19 on the market. Quick Buy Vaccine Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101769 North America to Command Owing to Presence of Several Vaccines Manufacturer in the Region North America is expected to hold a significant share as it generated a revenue of USD 24.88 billion in the year 2019. This region favors the market due to increased awareness of vaccination and the presence of major vaccine manufacturers in the region. The United States government spent USD 378 billion in 2018, and this marked an increase of 10.2% from 2017, reports the National Center of Science and Engineering Statistics. On the other hand, Asia Pacific is also expected to mark significant growth due to heterogeneous economies in the region. Japan is leading the vaccine industry in the region. Moreover, the rising population of India and China is also expected to promote the regional market. In the European region, France and Germany are expected to contribute to industry positively. Some of the prominent companies in the Vaccines Market are GlaxoSmithKline plc.SanofiPfizer Inc.Merck & Co., Inc.Novartis AGEmergent BioSolutions, Inc.CSL LimitedInovio Pharmaceuticals, Inc.Bavarian NordicMitsubishi Tanabe Pharma Corporation.Other Prominent Players Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/vaccines-market-101769 Detailed Table of Content: Introduction Research ScopeMarket SegmentationResearch MethodologyDefinitions and Assumptions Executive SummaryMarket Dynamics Market DriversMarket RestraintsMarket Opportunities Key Insights New Product Launch Pipeline AnalysisTechnological Advancements in the Vaccines MarketPrevalence of Disease IndicationsKey Industry Developments - Mergers, Acquisitions, and Partnerships Global Vaccines Market Analysis, Insights and Forecast, 2015-2026 Key Findings / SummaryMarket Analysis, Insights and Forecast – By Type Recombinant/Conjugate/SubunitInactivatedLive AttenuatedToxoid Market Analysis, Insights and Forecast – By Route of Administration ParenteralOral Market Analysis, Insights and Forecast – By Disease Indication Viral DiseasesBacterial Diseases Market Analysis, Insights and Forecast – By Age Group PediatricAdults Market Analysis, Insights and Forecast – By Distribution Channel Hospital & Retail PharmaciesGovernment SuppliersOthers Market Analysis, Insights and Forecast – By Geography North AmericaEuropeAsia pacificLatin AmericaMiddle East & Africa North America Vaccines Market Analysis, Insights and Forecast, 2015-2026 Key Findings / SummaryMarket Analysis, Insights and Forecast – By Type Recombinant/Conjugate/SubunitInactivatedLive AttenuatedToxoid Market Analysis, Insights and Forecast – By Route of Administration ParenteralOral Market Analysis, Insights and Forecast – By Disease Indication Viral DiseasesBacterial Diseases Market Analysis, Insights and Forecast – By Age Group PediatricAdults Market Analysis, Insights and Forecast – By Distribution Channel Hospital & Retail PharmaciesGovernment SuppliersOthers Market Analysis, Insights and Forecast – By Country U.S.Canada Europe Vaccines Market Analysis, Insights and Forecast, 2015-2026 Key Findings / SummaryMarket Analysis, Insights and Forecast – By Type Recombinant/Conjugate/SubunitInactivatedLive AttenuatedToxoid Market Analysis, Insights and Forecast – By Route of Administration ParenteralOral Market Analysis, Insights and Forecast – By Disease Indication Viral DiseasesBacterial Diseases Market Analysis, Insights and Forecast – By Age Group PediatricAdults Market Analysis, Insights and Forecast – By Distribution Channel Hospital & Retail PharmaciesGovernment SuppliersOthers Market Analysis, Insights and Forecast – By Country/Sub-region U.K.GermanyFranceSpainItalyScandinaviaRest of Europe TOC Continued…..!!!!! Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/vaccines-market-101769 Have a Look at Related Reports: E-prescribing Market Size, Share & Industry Analysis, By Delivery Mode (Web-based, On-premise), By Prescription Type (Controlled substance, Non controlled Substances) By End User (Hospitals, Physician's offices, Pharmacies) and Regional Forecast, 2019-2026 Contact Lenses Market Size, Share & Industry Analysis, By Modality (Reusable and Disposable), By Design (Toric, Multi-focal, and Spherical), By Distribution Channel (Retail Stores, Online Stores, and Ophthalmlogists), and Regional Forecast, 2019-2026 Wearable Medical Devices Market Size, Share and Global Trend By Product (Diagnostic & Patient Monitoring Wearable Medical Devices, Therapeutic Wearable Medical Devices), By Application (Remote Patient Monitoring and Home Healthcare, Sports and Fitness), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hypermarkets) and Geography Forecast till 2026Plasma Fractionation Market Size, Share & Industry Analysis, By Product Type (Albumin, Immunoglobulin (Intravenous Immunoglobulin and Subcutaneous Immunoglobulin), Coagulation Factors, Protease Inhibitors and Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology and Others), By End User (Hospitals & Clinics,) and Geography Forecast, 2019-2026 About Us: Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges. Contact Us: Fortune Business Insights™ Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India. Phone:US :+1 424 253 0390UK : +44 2071 939123APAC : +91 744 740 1245Email: email@example.comFortune Business Insights™LinkedIn | Twitter | Blogs Press Release: https://www.fortunebusinessinsights.com/press-release/vaccines-market-9430
The "Saudi Arabia Facility Management Market, By Service (Property, Cleaning, Security, Support, Catering & Others), By End User (Commercial, Industrial & Residential), Competition, Forecast & Opportunities, 2014 - 2024" report has been added to ResearchAndMarkets.com's offering.
VANCOUVER, British Columbia, May 17, 2021 (GLOBE NEWSWIRE) -- Golden Predator Mining Corp. (TSX.V: GPY; OTCQX: NTGSF) ("Golden Predator") announces that the Company has filed a Notice of Civil Claim in the Supreme Court of British Columbia on behalf of Janet Lee-Sheriff, CEO, and Golden Predator, Plaintiffs, against the Government of Yukon and Paul Christman (who was at all material times employed as the Chief Mine Engineer for the Government of Yukon) Defendants. The claim alleges that Mr. Christman, in the course of his employment with the Government of Yukon in 2020, falsely and maliciously spoke of and concerning Ms. Lee-Sheriff and Golden Predator. Mr. Christman has since left the position of Chief Mine Engineer for the Government of Yukon. The claim seeks relief against Mr. Christman and the Government of Yukon, including declarations concerning the defamations alleged, production of documents relating to Mr. Christman’s dealings and influence arising from his role in the Government of Yukon affecting Golden Predator, and general damages arising from the misconduct alleged. The allegations have not yet been proven in Court. Golden Predator will continue to focus on advancing its Brewery Creek project in the Yukon through the permitting renewal process. ABOUT GOLDEN PREDATOR MINING CORP.Golden Predator is advancing the past-producing Brewery Creek Mine towards a timely resumption of mining activities in Canada’s Yukon. The project has established resources grading over 1.0 g/t Gold and both a technical report and Bankable Feasibility Study underway to define the economics of a restart of heap leach operations at the Brewery Creek Mine. The 180 km2 brownfield property is located 55 km by road from Dawson City, Yukon and operates under a Socio-Economic Accord with the Tr’ondëk Hwëch’in First Nation. The Company also holds the Marg Project, with a 43-101 compliant resource, the Gold Dome Project and Grew Creek Project. For additional information on Golden Predator and the Brewery Creek Mine, please visit our website: www.goldenpredator.com. FOR ADDITIONAL INFORMATION: GOLDEN PREDATOR MINING CORP.William Harris, Independent Director(604) firstname.lastname@example.org Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announces financial results for the three months ended March 31, 2021. During the first quarter of 2021 the company raised proceeds of $34.5 million from two equity financings and $10 million from the exercise of warrants issued to investors in previous offerings. Titan also announces changes to its board of directors appointing Paul Cataford as Chairman of the Board and Heather Knight as an independent member of the board. In addition, Cathy Steiner has been nominated for election to the Board at the annual and special meeting of shareholders on June 9, 2021.
2020 and 2021 - Sales 2020 and 2021 - Sales MONTREAL, May 17, 2021 (GLOBE NEWSWIRE) -- Dynacor Gold Mines Inc. (TSX: DNG / OTC: DNGDF) (Dynacor or the Corporation) released its unaudited consolidated financial statements and the management's discussion and analysis (MD&A) for the first quarter ended March 31, 2021. These documents have been filed electronically with SEDAR at www.sedar.com and will be available on the Corporation's website www.dynacor.com. (All figures in this press release are in Ms of US$ unless stated otherwise. All amounts per share are in US$. All variance % are calculated from rounded figures. Some additions might be incorrect due to rounding). Q1-2021 OVERVIEW AND HIGHLIGHTS OVERVIEW Dynacor completed the three-month period ended March 31, 2021 (“Q1-2021”) with quarterly record sales of $40.9 million and a net income of $2.1 million (US$0.05 per share), ahead of annual guidance, compared to sales of $30.9 million and a net income of $2.4 million (US$0.06 per share) in the first quarter of 2020 (“Q1-2020”). Despite the annual rainy season period in Peru, the Corporation continued attracting a large volume of ore, purchasing 32,135 tonnes which is just under the level of purchases in Q4-2020. This resulted as well in the highest Q1 gold production in the Corporation’s history. Despite a slightly declining gold market price, the Corporation was able to increase its quarterly sales for the third consecutive quarter. Compared to last year, the increase in sales is even more remarkable given that Q1-2020 sales included approximately $8.7 million coming from December 2019 postponed gold exports. The Corporation also recently announced a $1.8 million investment through internally generated cash flow to expand its Veta Dorada ore processing plant capacity. The new plant expansion will enable to increase production, improve cost efficiencies, create jobs and elevate Dynacor as Peru's largest ASM gold ore purchaser and processer. HIGHLIGHTS Operational Highest quarterly volume processed. In Q1-2021 the Veta Dorada plant processed a volume of 29,327 tonnes of ore (326 tpd) compared to 22,901 tonnes (297 tpd) in Q1-2020 a 28.1% increase and historical Q1 high. (Considering 90 days in Q1-2021 and 77 potential working days due to Covid-19 restrictions plant shut-down in Q1-2020);Significant increase in quarterly production. During Q1-2021, gold equivalent production amounted to 21,975 AuEq ounces compared to 13,542 AuEq ounces in Q1-2020, representing an increase of 62.3%; Increase in ore inventory despite the annual rainy season. With an ore purchase volume of 32,135 tonnes in Q1-2021, the Corporation completed Q1-2021 with a level of inventory exceeding 11,000 tonnes. Consequently, the Corporation decided to bring forward the mill expansion. Financial 32.4% increase in Sales. With higher quantities and average gold market price, sales amounted to $40.9 million in Q1-2021 compared with $30.9 million in Q1-2020;Increased gross operating margin. Gross operating margin of $5.3 million in Q1-2021, an increase of 8.2% compared to $4.9 million in Q1-2020;Quarter to quarter increase in Net income. Net income and comprehensive income of $2.1 million ($0.05 per share) compared to $1.4 million in Q4-2020 and $2.4 million in Q1-2020;Strong cash gross operating margin. Cash gross operating margin of $257 per AuEq ounce sold (1) compared to $283 in Q1-2020;Increased EBITDA(2). $4.6 million compared to $4.3 million in Q1-2020;Stable cash-flow from operating activities before change in working capital items. Cash flow from operating activities before change in working capital items of $3.1 million ($0.08 per share) (3) similar to Q1-2020;Improved cash position. Cash on hand of $17.2 million at March 31, 2021 compared to $11.9 million at year-end 2020. Cash Return to Shareholders Change in dividend policy. Starting in February 2021, a CA$0.005 monthly dividend per share is paid replacing the CA$0.015 quarterly dividend. During Q1-2021, dividends totaling $0.8 million (CA$ 1.0 million) were paid. (1) Cash gross operating margin per AuEq ounce is in US$ and is calculated by subtracting the average cash cost of sale per equivalent ounces of Au from the average selling price per equivalent ounces of Au and is a non-IFRS financial performance measure with no standard definition under IFRS. It is therefore possible that this measure could not be comparable with a similar measure of another company. (2) EBITDA: “Earnings before interest, taxes and depreciation” is a non-IFRS financial performance measure with no standard definition under IFRS. It is therefore possible that this measure could not be comparable with a similar measure of another corporation. The Corporation uses this non-IFRS measure as an indicator of the cash generated by the operations and allows investor to compare the profitability of the Corporation with others by canceling effects of different assets bases, effects due to different tax structures as well as the effects of different capital structures. (3) Cash-flow per share is a non-IFRS financial performance measure with no standard definition under IFRS. It is therefore possible that this measure could not be comparable with a similar measure of another corporation. The Corporation uses this non-IFRS measure which can also be helpful to investors as it provides a result which can be compared with the Corporation market share price. RESULTS FROM OPERATIONS Extract from Consolidated Statement of net income and comprehensive income For the three-month periods ended March 31, (in $'000) (unaudited)20212020 Sales40,90930,869Cost of sales(35,606)(25,920)Gross operating margin 5,3034,949General and administrative expenses(1,208)(1,091)Other project expenses(16)(128)Operating income 4,0793,730Income before income taxes3,9283,647Current income tax expense(1,554)(1,223)Deferred income tax expense,(268)(39)Net income and comprehensive income2,1062,385 Earnings per share Basic$0.05$0.06Diluted$0.05$0.06 Total sales amounted to $40.9 million compared to $30.9 million in Q1-2020. The $10.0 million increase is explained by higher volume of gold sold ($5.4 million) at a higher average gold price ($4.6 million). The Q1-2021 gold production also beneficiated from a significantly higher gold recovery (+3.4%) compared to Q1-2020. The Q1-2021 gross operating margin reached $5.3 million which represents 13.0% of sales. This level is higher than the forecast of the Corporation. Compared to 2020, the gross operating margin was negatively impacted by the declining trend of gold market price. General and administrative expenses amounted to $1.2 million in Q1-2021, a $0.1 million increase compared to Q1-2020. The Q1-2021 net income was impacted by the recording of a $0.3 million deferred income tax expense resulting from FX variances between the $US and the Peruvian Sol applying on long term assets local tax basis. Reconciliation of non-IFRS measures (in $'000) (unaudited)For the three-month periods ended March 31, 20212020Reconciliation of net income and comprehensive income to EBITDA Net income and comprehensive income2,1062,385Income taxes expense (current and deferred)1,8211,262Financial expenses5118Depreciation643640EBITDA 4,6214,305 CASH FLOW FROM OPERATING, INVESTING AND FINANCING ACTIVITIES AND WORKING CAPITAL AND LIQUIDITY Operating activities For the three-month period ended March 31, 2021, the cash flow from operations, before changes in working capital items, amounted to $3.1 million, similar to last year. Net cash from operating activities amounted to $6.8 million compared to $13.1 million for the three-month period ended March 31, 2020. Changes in working capital items amounted to $3.7 million compared to $9.8 million in Q1-2020. Investing activities During the three-month period ended March 31, 2021, the Corporation invested $0.5 million (very limited investments in the comparative period). This amount is mainly comprised of investments at the plant notably in relation to the increase in capacity and improvements in production processes and to new vehicles. Financing activities In Q1-2021, with the change in dividend policy, three dividends totaling CA$0.025 per share were disbursed for a total consideration of $0.8 million (CA$ 1.0 million). In Q1-2020, a quarterly dividend was disbursed for a total consideration of $0.4 million (CA$ 0.6 million). During the period, 51,225 common shares were repurchased under the Corporation’s normal course issuer bid share buyback program for a total cash consideration of $0.08 million or CA$ 0.1 million (none in Q1-2020). Working capital and liquidity As at March 31, 2021, the Corporation’s working capital amounted to $27.4 million, including $17.2 million in cash ($25.4 million, including $11.9 million in cash as at December 31, 2020). CONSOLIDATED STATEMENT OF FINANCIAL POSITION As at March 31, 2021, total assets amounted to $78.4 million ($76.3 million as at December 31, 2020). Major variances since last year-end come from the significant increase in cash, the decrease in inventories mainly due to the decrease in gold in process and the impact of the additional deferred tax liability recorded in Q1-2021. (in $'000) (unaudited)As at March 31,As at December 31, 20212020Cash17,23911,868Accounts receivable7,1778,434Inventories11,43313,401Property, plant and equipment19,70719,677Right-of-use assets654834Exploration and evaluation assets18,50818,510Other assets3,7293,572Total assets78,44776,296 Trade and other payables7,0317,082Asset retirement obligations3,5673,604Current tax liabilities1,5371,124Deferred tax liabilities1,3041,036Lease liabilities631706Shareholders' equity64,37762,744Total liabilities and equity78,44776,296 OUTLOOK 2021 Ore processing Contrary to previous years and despite the annual rainy season, the Corporation was able to even increase its ore inventory during Q1-2021. With this inventory level and current strong ore purchases, the Corporation has initiated in March ahead of its initial planned schedule the expansion project of its Veta Dorada processing plant which will increase the throughput level from its actual 345 tpd to 430 tpd, an increase of 25.0%. The expansion is scheduled to be completed on time and on budget. For 2021, the Corporation issued financial and capital expenditure guidance(1), forecasting $150.0 million in sales and a net income of $6.9 million (US$0.18 per share). As at March 31, 2021, the Corporation is slightly ahead of its 2021 financial guidance. On May 13, the Corporation released its April 2021 monthly sales figure which amounted to $12.5 million (unaudited). ANNUAL MEETING OF SHAREHOLDERS On May 14, 2021, Dynacor filed its management proxy circular and related materials for its annual meeting of shareholders (the “Meeting”), which will be held at 1, Place Ville Marie, 40th Floor, Montréal, Québec H3B 4M4 and via live webcast at https://lavery.zoom.us/j/62888814122 on June 17, 2021. Due to restrictions relating to the global COVID-19 pandemic and to mitigate risks to the health and safety of our communities, shareholders, employees and other stakeholders, Dynacor strongly encourages shareholders to vote by proxy in advance of the Meeting and not to attend the Meeting in person. Shareholders may attend the Meeting via live webcast, where all shareholders, regardless of geographic location and equity ownership will have an equal opportunity to participate and engage with the Corporation, as well as other shareholders. Shareholders who have questions or require voting assistance may contact Dynacor’s shareholder communication advisor and proxy solicitation agent, Laurel Hill Advisory Group, by telephone at 1-877-452-7184 (toll-free in North America) or 1-416-304-0211 (collect call outside North America) or by email at email@example.com. (1) Assumptions i) average CA/US exchange rate of 1.273:1ii) 2021 financial guidance is based on an average gold price of $US 1,850 per ounce (Year-end 2020 rate). ABOUT DYNACOR Dynacor is a dividend-paying industrial gold ore processor headquartered in Montreal, Canada. The corporation is engaged in gold production through the processing of ore purchased from the ASM (artisanal and small-scale mining) industry. At present, Dynacor operates in Peru, where its management and processing teams have decades of experience working with ASM miners. It also owns a gold exploration property (Tumipampa) in the Apurimac department. The corporation intends to expand its processing operations in other jurisdictions as well. Dynacor produces environmental and socially responsible gold through its PX IMPACT® gold program. A growing number of supportive firms from the fine luxury jewelry, watchmakers and investment sectors pay a small premium to our customer and strategic partner for this PX IMPACT® gold. The premium provides direct investment to develop health and education projects for our artisanal and small-scale miner’s communities. Dynacor is listed on the Toronto Stock Exchange (DNG) and the OTC in the United States under the symbol (DNGDF). FORWARD-LOOKING INFORMATION Certain statements in the preceding may constitute forward-looking statements, which involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Dynacor, or industry results, to be materially different from any future result, performance or achievement expressed or implied by such forward-looking statements. These statements reflect management’s current expectations regarding future events and operating performance as of the date of this news release. Toronto Stock Exchange (TSX): DNGOTC (United States): DNGDF Shares Outstanding: 38,727,524 Website: http://www.dynacor.comTwitter: http://twitter.com/DynacorGold PDF available: http://ml.globenewswire.com/Resource/Download/327feff3-6a4e-443a-9511-88b9ee670337 A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5b981dbc-949d-4567-b35b-f5d9cec598b0 CONTACT: CONTACT: For more information, please contact: Director, Shareholder Relations Dale Nejmeldeen Dynacor Gold Mines Inc. T: 514-393-9000 #230 E: firstname.lastname@example.org